Potential Mechanisms of Interstitial Lung Disease Induced by Antibody–Drug Conjugates Based on Quantitative Analysis of Drug Distribution
Shigehiro Koganemaru(National Cancer Center Hospital East), Masahiro Yasunaga(Japan Clinical Cancer Research Organization)
Cited by 13
Related Papers
Significant antitumor effect of an antibody against TMEM180, a new colorectal cancer‐specific molecule
|Cancer Science|2018|22
The Tumor Immune Microenvironment and Therapeutic Efficacy of Trastuzumab Deruxtecan in Gastric Cancer
|Cancer Research Communications|2024|8
Expansion of mixed immune cells using CD3/CD161 co-stimulation for the treatment of cancer
|Scientific Reports|2023|2